Articles

Found results: 16338

Genetics

The gorilla genome

Geneticists have completed a complete decoding of the gorilla genome and found that about 15% of gorilla genes are closer to their human counterparts than to those contained in the DNA of chimpanzees.

13.03.2012
Cellular technologies

Transplantation from immunocompatible donors: the first success

Five out of eight patients within a year after kidney transplantation, who did not fit them according to immunological parameters, together with hematopoietic stem cells from donors, were able to refuse to take immunosuppressants.

13.03.2012
Exhibitions and conferences

Life Sciences Invest – 2012

The II International Forum Life Sciences Invest (Partnering Russia) will be held in St. Petersburg on November 01-02, 2012.

13.03.2012
Controversial

Cleanliness is harmful to health

While working on this book , the scientific writer and biologist R.Dunn changed its working title "Living clean is harmful" to a more complex version of "The inhabitants of our body: predators, parasites and partners that shape the appearance of modern people."

11.03.2012
Biomedicine

Bacteria for cancer treatment

Perhaps the final stage in the development of cancer treatment methods with the help of bacteria will be combined approaches, when chemotherapy drugs will affect the tumor from the outside, and microorganisms will kill it from the inside.

11.03.2012
Other life sciences

How to teach fat cells to burn calories?

The protein PRDM16 – a possible target of future drugs for the treatment of obesity – can work as a "switch" that turns calorie-storing white fat cells into calorie-burning brown fat cells.

11.03.2012
Biotechnologies - into life

Neolactoferrin rushes to the market

There is no human lactoferrin as a marketable product on the world market. The production of the drug "Neolactoferrin" from the milk of transgenic goats will allow Transgenpharm to occupy a worthy niche in the global biotechnology market.

07.03.2012
Innovative Russia

Grants of "Dynasty" – to young biologists

The names of ten winners of the competition of young scientists specializing in the field of molecular and cellular biology have been announced.

07.03.2012
Nanotechnology

Nanotechnology a la russe

World experts quote few articles by Russian scientists working in the field of nanotechnology, and the situation with obtaining patents by Russian organizations on this topic is depressing.

07.03.2012
Biotechnologies - into life

Another biomedical acquisition of Rusnano

Rusnano and the American venture fund Domain Associates are investing $760 million in the development and production of innovative medicines.

07.03.2012
Biomedicine

One more step to victory over Parkinsonism

Scientists are already testing the drug CLR01 on a mouse model of Parkinson's disease and hope that this study will allow us to move on to clinical trials of the compound.

06.03.2012
Cellular technologies

Regeneration instead of transplantation

The technique of changing the expression of genes that control the differentiation of progenitor cells will regenerate hepatocytes and reduce the number of patients on the waiting list for liver transplantation.

06.03.2012
Cloning

Another clone attack

Rumors that tissue samples of ancient animals found in Yakutia will be sent to the world's leading institutions for possible cloning turned out to be greatly exaggerated.

06.03.2012
Nanotechnology

We catch single cancer cells in the blood

The "laboratory on a chip" developed at the University of Washington makes it possible to detect and isolate very small concentrations of cancer cells in a 1 ml blood sample.

05.03.2012
Healthy skepticism

Buy miracle remedies!

Correspondent of the portal ProKazan.ru I chose 5 of the strangest remedies "from everything" and biologically active additives, and also talked to their sellers under the guise of a customer.

05.03.2012
Biomedicine

Exactly into cancer, without spoiling healthy cells

Rigosertib allows cancer cells to start the process of division, and then leaves them without energy, destroying them in the very middle of mitosis. Healthy cells do not suffer at the same time.

05.03.2012
Biomedicine

Cabozatinib against prostate cancer

The first stage of clinical trials of cabozatinib involving 108 men suffering from prostate cancer with bone metastases ended with very encouraging results.

02.03.2012